GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Beijing Science Sun Pharmaceutical Co Ltd (SZSE:300485) » Definitions » Cyclically Adjusted Price-to-FCF

Beijing Science Sun Pharmaceutical Co (SZSE:300485) Cyclically Adjusted Price-to-FCF : 28.39 (As of Jun. 08, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Beijing Science Sun Pharmaceutical Co Cyclically Adjusted Price-to-FCF?

As of today (2024-06-08), Beijing Science Sun Pharmaceutical Co's current share price is ¥6.53. Beijing Science Sun Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥0.23. Beijing Science Sun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF for today is 28.39.

The historical rank and industry rank for Beijing Science Sun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

SZSE:300485' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 31.13   Med: 43.15   Max: 49.79
Current: 32.14

During the past years, Beijing Science Sun Pharmaceutical Co's highest Cyclically Adjusted Price-to-FCF was 49.79. The lowest was 31.13. And the median was 43.15.

SZSE:300485's Cyclically Adjusted Price-to-FCF is ranked worse than
50.31% of 322 companies
in the Drug Manufacturers industry
Industry Median: 31.865 vs SZSE:300485: 32.14

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Beijing Science Sun Pharmaceutical Co's adjusted free cash flow per share data for the three months ended in Mar. 2024 was ¥0.074. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is ¥0.23 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Beijing Science Sun Pharmaceutical Co Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Beijing Science Sun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Science Sun Pharmaceutical Co Cyclically Adjusted Price-to-FCF Chart

Beijing Science Sun Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 47.36

Beijing Science Sun Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.20 42.17 48.88 47.36 36.92

Competitive Comparison of Beijing Science Sun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Science Sun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Science Sun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Beijing Science Sun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Beijing Science Sun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.



Beijing Science Sun Pharmaceutical Co Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Beijing Science Sun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=6.53/0.23
=28.39

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Science Sun Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Beijing Science Sun Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.074/115.2271*115.2271
=0.074

Current CPI (Mar. 2024) = 115.2271.

Beijing Science Sun Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.190 98.200 0.223
201409 0.112 98.900 0.130
201412 0.245 99.000 0.285
201503 -0.031 99.900 -0.036
201506 0.349 99.500 0.404
201509 0.293 100.500 0.336
201512 0.036 100.600 0.041
201603 0.032 102.200 0.036
201606 0.053 101.400 0.060
201609 0.062 102.400 0.070
201612 -0.010 102.600 -0.011
201703 -0.102 103.200 -0.114
201706 0.047 103.100 0.053
201709 0.031 104.100 0.034
201712 -0.045 104.500 -0.050
201803 0.014 105.300 0.015
201806 -0.015 104.900 -0.016
201809 -0.010 106.600 -0.011
201812 -0.095 106.500 -0.103
201903 -0.045 107.700 -0.048
201906 0.096 107.700 0.103
201909 0.008 109.800 0.008
201912 0.074 111.200 0.077
202003 0.041 112.300 0.042
202006 0.168 110.400 0.175
202009 0.109 111.700 0.112
202012 -0.003 111.500 -0.003
202103 0.043 112.662 0.044
202106 0.084 111.769 0.087
202109 0.110 112.215 0.113
202112 0.050 113.108 0.051
202203 0.028 114.335 0.028
202206 0.079 114.558 0.079
202209 0.036 115.339 0.036
202212 -0.004 115.116 -0.004
202303 -0.007 115.116 -0.007
202306 0.017 114.558 0.017
202309 -0.024 115.339 -0.024
202312 -0.049 114.781 -0.049
202403 0.074 115.227 0.074

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Beijing Science Sun Pharmaceutical Co  (SZSE:300485) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Beijing Science Sun Pharmaceutical Co Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Beijing Science Sun Pharmaceutical Co's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Science Sun Pharmaceutical Co (SZSE:300485) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Xingsheng Street, Yizhuang Economic and Technological Development Zone, Beijing, CHN, 100176
Beijing Science Sun Pharmaceutical Co Ltd is engaged in the research and development, production and sales of biological drugs. The company products can be divided into cardiovascular series, immune regulation series, nervous system series, and other natural or biotech pharmaceuticals. Its products include Injection Tiopronin, Cybex, Xel, Lichinga, Plasmin Injection and Race liter.
Executives
Ma Li Directors, executives
Kong Shuang Quan Executives
Li Jian Hua Director
Ma Biao Directors, executives
Li Zhi Bing Supervisors
Zhang Fan Executives

Beijing Science Sun Pharmaceutical Co (SZSE:300485) Headlines

No Headlines